(Q40100311)
Statements
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (English)
Farbod Shojaei
Xiumin Wu
Cuiling Zhong
Megan E Baldwin
Stefanie Schanz
Germaine Fuh
Hans-Peter Gerber
scientific article